Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 4,600 shares at $119.00 ($547K) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $547k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |
| BPMC | SELL | 2020-03-25 | $64K | — | Filing → |